<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">36188433</PMID><DateRevised><Year>2024</Year><Month>10</Month><Day>05</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">2589-5370</ISSN><JournalIssue CitedMedium="Internet"><Volume>54</Volume><PubDate><Year>2022</Year><Month>Dec</Month></PubDate></JournalIssue><Title>EClinicalMedicine</Title><ISOAbbreviation>EClinicalMedicine</ISOAbbreviation></Journal><ArticleTitle>Lung-function trajectories in COVID-19 survivors after discharge: A two-year longitudinal cohort study.</ArticleTitle><Pagination><StartPage>101668</StartPage><MedlinePgn>101668</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">101668</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.eclinm.2022.101668</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="UNASSIGNED">Data on the long-term trajectories of lung function are scarce in COVID-19 survivors.</AbstractText><AbstractText Label="METHODS" NlmCategory="UNASSIGNED">We re-analyzed the data from a prospective longitudinal cohort follow-up study of COVID-19 survivors over 2 years after infection. All participants were divided into scale 3, scale 4 and scale 5-6 groups according to seven-category ordinal scale. The changes of pulmonary function tests (PFTs), the Modified Medical Research Council (mMRC) Dyspnea Scale, 6-min walking test health-related quality of life (HRQoL) across the three serial follow-up visits were evaluated, and compared among three groups. We performed liner regression to determine potential factors that were associated with changes of PFTs and distance walked in 6 minutes (6MWD).</AbstractText><AbstractText Label="FINDINGS" NlmCategory="UNASSIGNED">In this study, 288 participants generally presented an improvement of PFTs parameters from 6 months to 1 year after infection. The scale 5-6 group displayed a significantly higher increase of PFTs compared with scale 3 and scale 4 groups (all <i>p</i>&lt;0.0167), and corticosteroids therapy was identified as a protective factor for the PFTs improvement with a correlation coefficient of 2.730 (0.215-5.246) for forced vital capacity (FVC), 2.909 (0.383-5.436) for total lung capacity (TLC), and 3.299 (0.211-6.387) for diffusion capacity for carbon monoxide (DLco), respectively. From 1-year to 2-year follow-up, the PFTs parameters generally decreased, which was not observed to be associated with changes of 6MWD and HRQoL. Dyspnea (mMRC&#x2265;1) generally decreased over time (23.3% [61/262] for 6-month, 27.9% [67/240] for 1-year, 13.4% [35/261] for 2-year), and 6MWD increased continuously (500.0&#xa0;m vs 505.0&#xa0;m vs 525.0&#xa0;m).</AbstractText><AbstractText Label="INTERPRETATION" NlmCategory="UNASSIGNED">Corticosteroids therapy during hospitalization was a protective factor for PFTs improvement from 6 months to 1 year. The relatively fast decline trend of PFTs from 1 year to 2 years needs to be paid attention and further validated in the future follow-up study.</AbstractText><AbstractText Label="FUNDINGS" NlmCategory="UNASSIGNED">This work was supported by Chinese Academy of Medical Sciences Innovation Fund for Medical Sciences (CIFMS 2021-I2M-1-048) and the National Key Research and Development Program of China (2021YFC0864700).</AbstractText><CopyrightInformation>&#xa9; 2022 The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Hui</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Pulmonary and Critical Care Medicine, China-Japan Friendship hospital, Capital Medical University, Beijing, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Pulmonary and Critical Care Medicine, Center of Respiratory Medicine, Institute of Respiratory Medicine, Chinese Academy of Medical Sciences, National Clinical Research Center for Respiratory Diseases, China-Japan Friendship Hospital, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Xia</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Hubei Provincial Clinical Research Center for Infectious Diseases, Wuhan Research Center for Communicable Disease Diagnosis and Treatment, Chinese Academy of Medical Sciences, Wuhan, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Huang</LastName><ForeName>Lixue</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Pulmonary and Critical Care Medicine, China-Japan Friendship hospital, Capital Medical University, Beijing, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Pulmonary and Critical Care Medicine, Center of Respiratory Medicine, Institute of Respiratory Medicine, Chinese Academy of Medical Sciences, National Clinical Research Center for Respiratory Diseases, China-Japan Friendship Hospital, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gu</LastName><ForeName>Xiaoyin</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Department of Clinical Research and Data Management, Center of Respiratory Medicine, China-Japan Friendship Hospital; Institute of Respiratory Medicine, Chinese Academy of Medical Sciences; National Clinical Research Center for Respiratory Diseases, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Yimin</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Pulmonary and Critical Care Medicine, Center of Respiratory Medicine, Institute of Respiratory Medicine, Chinese Academy of Medical Sciences, National Clinical Research Center for Respiratory Diseases, China-Japan Friendship Hospital, Beijing, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Pulmonary and Critical Care Medicine, Hubei Provincial Clinical Research Center for Infectious Diseases, Wuhan Research Center for Communicable Disease Diagnosis and Treatment, Chinese Academy of Medical Sciences, Wuhan, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Min</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Radiology, China-Japan Friendship Hospital, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Zhibo</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>Department of Pulmonary and Critical Care Medicine, Center of Respiratory Medicine, Institute of Respiratory Medicine, Chinese Academy of Medical Sciences, National Clinical Research Center for Respiratory Diseases, China-Japan Friendship Hospital, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Xueyang</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Tsinghua University School of Medicine, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yu</LastName><ForeName>Zhenxing</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>Department of Pulmonary and Critical Care Medicine, Hubei Provincial Clinical Research Center for Infectious Diseases, Wuhan Research Center for Communicable Disease Diagnosis and Treatment, Chinese Academy of Medical Sciences, Wuhan, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Yeming</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Pulmonary and Critical Care Medicine, Center of Respiratory Medicine, Institute of Respiratory Medicine, Chinese Academy of Medical Sciences, National Clinical Research Center for Respiratory Diseases, China-Japan Friendship Hospital, Beijing, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Changping Laboratory, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Huang</LastName><ForeName>Chaolin</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Hubei Provincial Clinical Research Center for Infectious Diseases, Wuhan Research Center for Communicable Disease Diagnosis and Treatment, Chinese Academy of Medical Sciences, Wuhan, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cao</LastName><ForeName>Bin</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Department of Pulmonary and Critical Care Medicine, China-Japan Friendship hospital, Capital Medical University, Beijing, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Pulmonary and Critical Care Medicine, Center of Respiratory Medicine, Institute of Respiratory Medicine, Chinese Academy of Medical Sciences, National Clinical Research Center for Respiratory Diseases, China-Japan Friendship Hospital, Beijing, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Tsinghua University School of Medicine, Beijing, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Changping Laboratory, Beijing, China.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>09</Month><Day>28</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>EClinicalMedicine</MedlineTA><NlmUniqueID>101733727</NlmUniqueID><ISSNLinking>2589-5370</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">Corticosteroids</Keyword><Keyword MajorTopicYN="N">Long COVID</Keyword><Keyword MajorTopicYN="N">Lung function</Keyword><Keyword MajorTopicYN="N">Pulmonary function tests</Keyword></KeywordList><CoiStatement>All authors declare no related conflict of interest in this paper.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>7</Month><Day>13</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2022</Year><Month>9</Month><Day>4</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>9</Month><Day>6</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>10</Month><Day>3</Day><Hour>5</Hour><Minute>8</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>10</Month><Day>4</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>10</Month><Day>4</Day><Hour>6</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2022</Year><Month>9</Month><Day>28</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36188433</ArticleId><ArticleId IdType="pmc">PMC9514976</ArticleId><ArticleId IdType="doi">10.1016/j.eclinm.2022.101668</ArticleId><ArticleId IdType="pii">S2589-5370(22)00398-4</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Fan E, Beitler JR, Brochard L, et al. COVID-19-associated acute respiratory distress syndrome: is a different approach to management warranted? Lancet Respir Med. 2020;8:816&#x2013;821.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7338016</ArticleId><ArticleId IdType="pubmed">32645311</ArticleId></ArticleIdList></Reference><Reference><Citation>Grasselli G, Tonetti T, Protti A, et al. Pathophysiology of COVID-19-associated acute respiratory distress syndrome: a multicentre prospective observational study. Lancet Respir Med. 2020;8:1201&#x2013;1208.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7834127</ArticleId><ArticleId IdType="pubmed">32861276</ArticleId></ArticleIdList></Reference><Reference><Citation>Bian X-W, The COVID-19 Pathology Team, Yao X-H, et al. Autopsy of COVID-19 patients in China. Natl Sci Rev. 2020;7:1414&#x2013;1418.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7313767</ArticleId><ArticleId IdType="pubmed">34192086</ArticleId></ArticleIdList></Reference><Reference><Citation>Tian S, Xiong Y, Liu H, et al. Pathological study of the 2019 novel coronavirus disease (COVID-19) through postmortem core biopsies. Mod Pathol. 2020;33:1007&#x2013;1014.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7156231</ArticleId><ArticleId IdType="pubmed">32291399</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu Z, Shi L, Wang Y, et al. Pathological findings of COVID-19 associated with acute respiratory distress syndrome. Lancet Respir Med. 2020;8:420&#x2013;422.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7164771</ArticleId><ArticleId IdType="pubmed">32085846</ArticleId></ArticleIdList></Reference><Reference><Citation>Antoniou KM, Vasarmidi E, Russell A-M, et al. European respiratory society statement on long COVID-19 follow-up. Eur Respir J. 2022;60</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9349784</ArticleId><ArticleId IdType="pubmed">35144991</ArticleId></ArticleIdList></Reference><Reference><Citation>George PM, Barratt SL, Condliffe R, et al. Respiratory follow-up of patients with COVID-19 pneumonia. Thorax. 2020;75:1009&#x2013;1016.</Citation><ArticleIdList><ArticleId IdType="pubmed">32839287</ArticleId></ArticleIdList></Reference><Reference><Citation>Iversen KK, Afzal S, Ahlstr&#xf6;m MG, et al. Lung function decline in relation to COVID-19 in the general population: a matched cohort study with prepandemic assessment of lung function. J Infect Dis. 2022;225:1308&#x2013;1316.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8755346</ArticleId><ArticleId IdType="pubmed">34979029</ArticleId></ArticleIdList></Reference><Reference><Citation>Anastasio F, Barbuto S, Scarnecchia E, et al. Medium-term impact of COVID-19 on pulmonary function, functional capacity and quality of life. Eur Respir J. 2021;58</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7877327</ArticleId><ArticleId IdType="pubmed">33574080</ArticleId></ArticleIdList></Reference><Reference><Citation>Eberst G, Claud&#xe9; F, Laurent L, et al. Result of one-year, prospective follow-up of intensive care unit survivors after SARS-CoV-2 pneumonia. Ann Intensive Care. 2022;12:23.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8905558</ArticleId><ArticleId IdType="pubmed">35262794</ArticleId></ArticleIdList></Reference><Reference><Citation>The Writing Committee for the COMEBAC Study Group Four-month clinical status of a cohort of patients after hospitalization for COVID-19. JAMA. 2021;325:1525&#x2013;1534.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7970386</ArticleId><ArticleId IdType="pubmed">33729425</ArticleId></ArticleIdList></Reference><Reference><Citation>Lombardi F, Calabrese A, Iovene B, et al. Residual respiratory impairment after COVID-19 pneumonia. BMC Pulm Med. 2021;21:241.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8286033</ArticleId><ArticleId IdType="pubmed">34273962</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu X, Liu X, Zhou Y, et al. 3-month, 6-month, 9-month, and 12-month respiratory outcomes in patients following COVID-19-related hospitalisation: a prospective study. Lancet Respir Med. 2021;9:747&#x2013;754.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8099316</ArticleId><ArticleId IdType="pubmed">33964245</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang C, Huang L, Wang Y, et al. 6-month consequences of COVID-19 in patients discharged from hospital: a cohort study. Lancet. 2021;397:220&#x2013;232.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7833295</ArticleId><ArticleId IdType="pubmed">33428867</ArticleId></ArticleIdList></Reference><Reference><Citation>Cao B, Wang Y, Wen D, et al. A trial of lopinavir-ritonavir in adults hospitalized with severe Covid-19. N Engl J Med. 2020;382:1787&#x2013;1799.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7121492</ArticleId><ArticleId IdType="pubmed">32187464</ArticleId></ArticleIdList></Reference><Reference><Citation>Miller MR, Hankinson J, Brusasco V, et al. Standardisation of spirometry. Eur Respir J. 2005;26:319&#x2013;338.</Citation><ArticleIdList><ArticleId IdType="pubmed">16055882</ArticleId></ArticleIdList></Reference><Reference><Citation>Pellegrino R, Viegi G, Brusasco V, et al. Interpretative strategies for lung function tests. Eur Respir J. 2005;26:948&#x2013;968.</Citation><ArticleIdList><ArticleId IdType="pubmed">16264058</ArticleId></ArticleIdList></Reference><Reference><Citation>Taha N, D'Amato D, Hosein K, et al. Longitudinal functional changes with clinically significant radiographic progression in idiopathic pulmonary fibrosis: are we following the right parameters? Respir Res. 2020;21:119.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7238541</ArticleId><ArticleId IdType="pubmed">32429952</ArticleId></ArticleIdList></Reference><Reference><Citation>Maher TM, Corte TJ, Fischer A, et al. Pirfenidone in patients with unclassifiable progressive fibrosing interstitial lung disease: a double-blind, randomised, placebo-controlled, phase 2 trial. Lancet Respir Med. 2020;8:147&#x2013;157.</Citation><ArticleIdList><ArticleId IdType="pubmed">31578169</ArticleId></ArticleIdList></Reference><Reference><Citation>Hoffmann-Vold A-M, Allanore Y, Alves M, et al. Progressive interstitial lung disease in patients with systemic sclerosis-associated interstitial lung disease in the EUSTAR database. Ann Rheum Dis. 2021;80:219&#x2013;227.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7815627</ArticleId><ArticleId IdType="pubmed">32988845</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang L, Yao Q, Gu X, et al. 1-year outcomes in hospital survivors with COVID-19: a longitudinal cohort study. Lancet. 2021;398:747&#x2013;758.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8389999</ArticleId><ArticleId IdType="pubmed">34454673</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang L, Li X, Gu X, et al. Health outcomes in people 2 years after surviving hospitalisation with COVID-19: a longitudinal cohort study. Lancet Respir Med. 2022;10(9):863&#x2013;876.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9094732</ArticleId><ArticleId IdType="pubmed">35568052</ArticleId></ArticleIdList></Reference><Reference><Citation>Mo X, Jian W, Su Z, et al. Abnormal pulmonary function in COVID-19 patients at time of hospital discharge. Eur Respir J. 2020;55 doi: 10.1183/13993003.01217-2020.</Citation><ArticleIdList><ArticleId IdType="doi">10.1183/13993003.01217-2020</ArticleId><ArticleId IdType="pmc">PMC7236826</ArticleId><ArticleId IdType="pubmed">32381497</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen M, Liu J, Peng P, et al. Dynamic changes of pulmonary diffusion capacity in survivors of non-critical COVID-19 during the first six months. EClinicalMedicine. 2022;43</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8735830</ArticleId><ArticleId IdType="pubmed">35018338</ArticleId></ArticleIdList></Reference><Reference><Citation>Frija-Masson J, Debray M-P, Gilbert M, et al. Functional characteristics of patients with SARS-CoV-2 pneumonia at 30 days post-infection. Eur Respir J. 2020;56</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7301832</ArticleId><ArticleId IdType="pubmed">32554533</ArticleId></ArticleIdList></Reference><Reference><Citation>Ngai JC, Ko FW, Ng SS, To K-W, Tong M, Hui DS. The long-term impact of severe acute respiratory syndrome on pulmonary function, exercise capacity and health status. Respirology. 2010;15:543&#x2013;550.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7192220</ArticleId><ArticleId IdType="pubmed">20337995</ArticleId></ArticleIdList></Reference><Reference><Citation>Xie L, Liu Y, Fan B, et al. Dynamic changes of serum SARS-Coronavirus IgG, pulmonary function and radiography in patients recovering from SARS after hospital discharge. Respir Res. 2005;6:5.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC545044</ArticleId><ArticleId IdType="pubmed">15638943</ArticleId></ArticleIdList></Reference><Reference><Citation>Hui DS, Wong KT, Ko FW, et al. The 1-year impact of severe acute respiratory syndrome on pulmonary function, exercise capacity, and quality of life in a cohort of survivors. Chest. 2005;128:2247&#x2013;2261.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7094276</ArticleId><ArticleId IdType="pubmed">16236881</ArticleId></ArticleIdList></Reference><Reference><Citation>Agarwal A, Rochwerg B, Lamontagne F, et al. A living WHO guideline on drugs for Covid-19. BMJ. 2020;370:m3379.</Citation><ArticleIdList><ArticleId IdType="pubmed">32887691</ArticleId></ArticleIdList></Reference><Reference><Citation>Corticosteroids. COVID-19 treatment guidelines.https://www.covid19treatmentguidelines.nih.gov/therapies/immunomodulators/corticosteroids/. Accessed 2 June 2022.</Citation></Reference><Reference><Citation>Bhimraj A, Morgan RL, Shumaker AH, et al. Infectious Diseases Society of America Guidelines on the Treatment and Management of Patients with COVID-19. Clin Infect Dis. 2022;5</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7197612</ArticleId><ArticleId IdType="pubmed">32338708</ArticleId></ArticleIdList></Reference><Reference><Citation>WHO Rapid Evidence Appraisal for COVID-19 Therapies (REACT) Working Group, Sterne JAC, Murthy S, et al. Association between administration of systemic corticosteroids and mortality among critically Ill patients with COVID-19: a meta-analysis. JAMA. 2020;324(13):1330&#x2013;1341.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7489434</ArticleId><ArticleId IdType="pubmed">32876694</ArticleId></ArticleIdList></Reference><Reference><Citation>Recovery Collaborative Group, Horby P, Lim WS, et al. Dexamethasone in hospitalized patients with Covid-19. N Engl J Med. 2021;384:693&#x2013;704.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7383595</ArticleId><ArticleId IdType="pubmed">32678530</ArticleId></ArticleIdList></Reference><Reference><Citation>Catal&#xe1;n IP, Mart&#xed; CR, Sota DP de la, et al. Corticosteroids for COVID-19 symptoms and quality of life at 1 year from admission. J Med Virol. 2022;94:205&#x2013;210.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8662039</ArticleId><ArticleId IdType="pubmed">34436783</ArticleId></ArticleIdList></Reference><Reference><Citation>Meduri GU, Tolley EA, Chinn A, Stentz F, Postlethwaite A. Procollagen types I and III aminoterminal propeptide levels during acute respiratory distress syndrome and in response to methylprednisolone treatment. Am J Respir Crit Care Med. 1998;158:1432&#x2013;1441.</Citation><ArticleIdList><ArticleId IdType="pubmed">9817690</ArticleId></ArticleIdList></Reference><Reference><Citation>Meduri GU, Golden E, Freire AX, et al. Methylprednisolone infusion in early severe ARDS: results of a randomized controlled trial. Chest. 2007;131:954&#x2013;963.</Citation><ArticleIdList><ArticleId IdType="pubmed">17426195</ArticleId></ArticleIdList></Reference><Reference><Citation>Su Y, Yuan D, Chen DG, et al. Multiple early factors anticipate post-acute COVID-19 sequelae. Cell. 2022;185:881&#x2013;895.e20.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8786632</ArticleId><ArticleId IdType="pubmed">35216672</ArticleId></ArticleIdList></Reference><Reference><Citation>Klein J, Wood J, Jaycox J, et al. Distinguishing features of Long COVID identified through immune profiling. medRxiv [Preprint] 2022;2022:22278592. doi: 10.1101/2022.08.09.22278592.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2022.08.09.22278592</ArticleId><ArticleId IdType="pmc">PMC10620090</ArticleId><ArticleId IdType="pubmed">37748514</ArticleId></ArticleIdList></Reference><Reference><Citation>Neas LM, Schwartz J. The determinants of pulmonary diffusing capacity in a national sample of U.S. adults. Am J Respir Crit Care Med. 1996;153:656&#x2013;664.</Citation><ArticleIdList><ArticleId IdType="pubmed">8564114</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee JS, Kim SO, Seo JB, et al. Longitudinal lung volume changes in patients with chronic obstructive pulmonary disease. Lung. 2013;191:405&#x2013;412.</Citation><ArticleIdList><ArticleId IdType="pubmed">23715996</ArticleId></ArticleIdList></Reference><Reference><Citation>Lorent N, Vande Weygaerde Y, Claeys E, et al. Prospective longitudinal evaluation of hospitalised COVID-19 survivors 3 and 12 months after discharge. ERJ Open Res. 2022;8</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8994962</ArticleId><ArticleId IdType="pubmed">35415186</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>